Contraceptive pill Yasmin continues to stir debate - The National: Following concerns that contraceptive pills containing the synthetic hormone drospirenone carry an increased risk of blood clots, panel members of the US Food and Drug Administration met in December to vote on whether the benefits outweighed the risks. They voted 15-11 in favour. However, research carried out by the Washington Monthly and the British Medical Journal has since found that four of the panel members had links to Bayer, the pharmaceutical company that manufactures two of the best known drospirenone-containing pills, Yaz and Yasmin.
Their relationships with Bayer were known to the FDA at the time of the review, but were not considered to be a cause for a "conflict of interest." All four panel members voted in support of drospirenone-containing pills. Meanwhile, another panel member with known concerns about drospirenone-containing products was, only days before the vote, prevented from taking part due to a "conflict of interest."
'via Blog this'
No comments:
Post a Comment